ABS course Map
-
desktop_windows
Breast Cancer Now summit statement on access to breast reconstruction
Baroness Delyth Morgan | ABS Conference 2023
15.05.2023 | Added: 15.05.2023
Classifications: Breast & Oncoplastic Surgery
Keywords: Breast Reconstruction
desktop_windowsWebcast desktop_windows -
desktop_windows
Familial breast cancer - risk assessment in primary care. A pilot Genomic Medicine Service Alliance
Mr Naren Basu | ABS Conference 2023
15.05.2023 | Added: 15.05.2023
Classifications: Breast Cancer Risk
Keywords: Familial Breast Cancer/ Family History
desktop_windowsWebcast desktop_windows -
desktop_windows
Are patients being appropriately consented for implant- based breast reconstruction (IBR)?
Miss Lisa Sheehan | ABS Conference 2023
15.05.2023 | Added: 15.05.2023
Classifications: Breast & Oncoplastic Surgery
Keywords: Implant based breast reconstruction
desktop_windowsWebcast desktop_windows -
desktop_windows
Lipomodelling post pre-pectoral reconstruction
Mr Riccardo Bonomi | ABS Conference 2023
15.05.2023 | Added: 15.05.2023
Classifications: Breast & Oncoplastic Surgery
Keywords: Lipomodelling/ Lipofilling
desktop_windowsWebcast desktop_windows -
desktop_windows
Tailoring the NAC pedicle for reduction mammoplasty - individualising patient care and safety
Miss Lorenza Caggiati | ABS Conference 2023
15.05.2023 | Added: 15.05.2023
Classifications: Breast & Oncoplastic Surgery
Keywords: Mammoplasty/ Breast Reduction
desktop_windowsWebcast desktop_windows -
desktop_windows
Complications and oncological safety of robotic vs. Open nipple sparring mastectomy- meta-analysis
Dr Ashrafun Nessa | ABS Conference 2023
15.05.2023 | Added: 15.05.2023
Classifications: Breast & Oncoplastic Surgery
Keywords: Nipple sparing
desktop_windowsWebcast desktop_windows -
desktop_windows
Systematic review comparing volume replacement oncoplastic surgery to all other surgical techniques
Dr Akriti Nanda | ABS Conference 2023
15.05.2023 | Added: 15.05.2023
Classifications: Breast & Oncoplastic Surgery
Keywords: Oncoplastic Surgery
desktop_windowsWebcast desktop_windows -
desktop_windows
ALDH1 and CD44 serve as prognostic markers in patients with breast cancer
Professor Diptendra Kumar Sarkar | ABS Conference 2023
15.05.2023 | Added: 15.05.2023
Classifications: Breast Cancer Treatment
Keywords: Prognostic Markers
desktop_windowsWebcast desktop_windows -
desktop_windows
Professor Nigel Bundred | ABS Conference 2023
15.05.2023 | Added: 15.05.2023
Classifications: Breast & Oncoplastic Surgery
Keywords: Surgical Margins
desktop_windowsWebcast desktop_windows -
desktop_windows
No tumour on ink is a sufficient margin
Dr Hiram S. Cody III | ABS Conference 2023
15.05.2023 | Added: 15.05.2023
Classifications: Breast & Oncoplastic Surgery
Keywords: Surgical Margins
desktop_windowsWebcast desktop_windows -
desktop_windows
Predictors of surgical site infection following breast surgery
Mrs Wajiha Tehniyat | ABS Conference 2023
15.05.2023 | Added: 15.05.2023
Classifications: Breast & Oncoplastic Surgery
Keywords: Surgical Site Infection/ SSI
desktop_windowsWebcast desktop_windows -
desktop_windows
Professor Cliona Kirwan | ABS Conference 2023
15.05.2023 | Added: 15.05.2023
Classifications: Breast & Oncoplastic Surgery
Keywords: VTE
desktop_windowsWebcast desktop_windows -
menu_book
Age and sex can predict cancer risk in people referred with breast symptoms
Over the last decade, more than 5 million patients were referred to secondary care with breast symptoms. In 2021-22, 40% of referred patients waited longer than the recommended 14 days for clinic asse...
Toral Gathani et al | British medical Journal
26.04.2023 | Added: 26.04.2023
Classifications: Breast Cancer Risk
Keywords: High risk factors
menu_bookPublication menu_book -
desktop_windows
ABS MDT Meeting: DCIS (Session 2)
n/a | MDT meeting 2023
25.01.2023 | Added: 25.01.2023
Classifications: Breast Cancer Treatment
Keywords: DCIS
desktop_windowsWebcast desktop_windows -
menu_book
The AMAROS trial evaluated axillary lymph node dissection (ALND; n=744) vs. axillary radiotherapy (ART; n=681) in patients with cT1-2 breast cancer with positive sentinel lymph node biopsy (SLNB). The...
Sanne A.L Bartels,MD,Phd,MSc et al | Journal of Clinical Oncology
16.11.2022 | Added: 16.11.2022
Classifications: Breast & Oncoplastic Surgery
Keywords: Axilla Sentinel Lymph Node Biopsy/ SLNB Trials Radiotherapy
menu_bookPublication menu_book -
menu_book
Targeted axillary dissection (TAD) involves targeted lymph node biopsy and SLNB. SenTa study is a prospective registry study conducted across 50 centres which aims to investigate the feasibility and a...
Sherko Kuemmel et al | National Library of Medicine
01.11.2022 | Added: 01.11.2022
Classifications: Breast & Oncoplastic Surgery
menu_bookPublication menu_book -
menu_book
This randomised controlled trial evaluated whether a single bolus dose of 1.2g intravenous Augmentin reduced wound infection at 30 days after breast cancer surgery. 438 patients received prophylactic ...
Sheila Stallard et al | British Journal of Surgery
06.09.2022 | Added: 06.09.2022
Classifications: Breast & Oncoplastic Surgery
Keywords: Antibiotic Prophylaxis Trials Breast Surgery
menu_bookPublication menu_book -
menu_book
This study aimed to determine potential association between postoperative complications and survival in breast cancer patients as postoperative complications may activate prometastatic pathways. Patie...
Jana de Boniface et al | British Journal of Surgery
05.08.2022 | Added: 05.08.2022
Classifications: Breast & Oncoplastic Surgery
Keywords: Breast Surgery Complications Trials
menu_bookPublication menu_book